Evidence map›Paper›PMID 42509515›Full record

ArticleJournal of racial and ethnic health disparities2026

Using a Community-Embedded Screening and Navigation Framework to Engage High-Risk Men in Prostate Cancer Early Detection: Five Years of the Men's Health Awareness Summit in Oklahoma.

Adam C Alexander, Jordan Neil, Valerie Moise, Yanet Trejo, Stephanie Pharr, Mark Doescher, Brittany L Hudson, Pragya Dhar, Brianna Fleshman, Jack Fronheiser and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Adam C AlexanderTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA. Adam-alexander@ou.edu.ORCID http://orcid.org/0000-0003-1448-4205
Jordan NeilTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Valerie MoiseStephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Yanet TrejoLynn Institute, Oklahoma City, OK, USA.
Stephanie PharrStephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Mark DoescherDepartment of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Campus, 655 Research Parkway, Suite 400, Oklahoma City, OK, 73104, USA.
Brittany L HudsonTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Pragya DharTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Brianna FleshmanTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Jack FronheiserTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Kimberly EstradaTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Iván FloresTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
David BradleyTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Starla JohnsonTSET Health Promotion Research Center, Stephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Michael CooksonStephenson Cancer Center, the University of Oklahoma Health Campus, Oklahoma City, OK, USA.

Funding

NIMHD NIH HHS 1K01MD015295-01A1
6 · The paper itself

Abstract

Prostate cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death among men in the United States. Black men experience the highest incidence and mortality and are more likely to be diagnosed at younger ages and with more advanced or aggressive disease. Because survival outcomes differ substantially by stage at diagnosis, community-based approaches that support early detection are needed. This paper describes the development and five-year evolution of the Men's Health Awareness Summit (MHAS), a community-led initiative in Oklahoma City, Oklahoma, launched during the COVID-19 pandemic through an academic-community partnership. MHAS combines culturally resonant education, survivor testimony, no-cost on-site PSA screening, and operational pathways for communicating results and facilitating referrals. Drawing on five consecutive summits, we synthesize practice-based implementation lessons related to (1) community governance; (2) actionable programming, results communication, and referral processes; (3) venue selection and community embedding; (4) outreach and word-of-mouth amplification; and (5) low-burden tracking paired with financial stewardship. We conceptualize these elements as a community-embedded screening and navigation framework and outline components that may support adaptation in other settings and screening contexts to strengthen equitable access to early detection, results communication, referral, and follow-up scheduling.

Indexed as

Black menCommunity-based screeningCommunity engagementHealth equityPatient navigationProstate cancer screening

Identifiers

PMID42509515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.